Richard J. Cote, M.D. Named Chief Medical Officer and Executive Vice President of Diamics, Inc.NOVATO, Calif. -- Diamics, Inc., a San Francisco Bay-area, medical device and diagnostics company, today announced that Richard J. Cote, M.D., FRCPath, has been named to the newly formed position of Chief Medical Officer and Executive Vice President. Dr. Cote was the founder of IMPATH, Inc., served on its Board of Directors, and was the company's Chief Strategic Consultant. In 2004, he repositioned ChromaVision (now Clarient, Inc.) into a successful services and biotech company, serving as Chief Medical Officer during that transition. Prior to joining Diamics, he headed Clarient's Scientific Advisory Board and was its Chief Strategic Consultant. Dr. Cote presently holds Professorships in the Department of Pathology and the Department of Urology at University of Southern California The U.S. News & World Report ranked USC 27th among all universities in the United States in its 2008 ranking of "America's Best Colleges", also designating it as one of the "most selective universities" for admitting 8,634 of the almost 34,000 who applied for freshman admission Keck School of Medicine/Norris Cancer Center in Los Angeles, where he also serves as Director of the Genitourinary genitourinary /gen·i·to·uri·nary/ (jen?i-to-u´ri-nar-e) pertaining to the genital and urinary organs. gen·i·to·u·ri·nar·y adj. Abbr. Program, Chair of the Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Nanoscience Committee, and Director of the Laboratory of Immunology and Molecular Pathology. A well known writer and lecturer, Dr. Cote is the author of two major textbooks in pathology. "Richard Cote is highly regarded in the international pathology community and is widely recognized both for his scientific and business achievements. His global reputation in medical research, medical education, clinical trials and biotechnology will be invaluable as Diamics advances and introduces its proprietary molecular-based diagnostics technologies," said Peter Gombrich, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Diamics, Inc. Dr. Cote is a prolific researcher and is internationally recognized for his work on molecular mechanisms of tumor progression and response to therapy. "I look forward to joining Diamics' experienced management team and to bringing this advanced cervical cancer screening system to millions of women around the globe," said Dr. Cote. Dr. Cote's interest in technology development has led to innovations in antigen and nucleic acid retrieval, novel applications of PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) (polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is ) technology, and development of novel nanotechnology platforms for disease diagnosis and evaluation. He is the recipient of numerous major research grants, holds several patents, and has participated on scientific advisory boards for both academic and industry-related institutions. Richard Cote received an M.D. from the University of Chicago Pritzker School of Medicine The Pritzker School of Medicine is the M.D. granting unit of the Biological Sciences Division of the University of Chicago. It is located on the University's main campus in the Hyde Park portion of Chicago proper, and matriculated its first class in 1927. (1980) and B.S. and B.A. degrees (Cum Laude) from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). , Irvine (1976). He is board certified by the American Board of Pathology and is a Fellow of the Royal College of Pathologists This article is about the British organisation. For other uses, see Royal College of Pathologists (disambiguation). The Royal College of Pathologists, was founded in 1962, and is a medical organisation that promotes and sets standards for the study and practice of . The recipient of many national and international awards, Dr. Cote is listed in "America's Top Doctors" and "The Best Doctors in America." About Diamics, Inc. Diamics Inc. is a privately owned medical device and diagnostics company located in Novato, California. The company is committed to developing, manufacturing, and marketing cost-effective, molecular-based cancer screening and diagnostic systems that will increase long-term survival rates through early detection. Diamics has a mature management team with an extensive track record in the medical device and diagnostics industries. The company's goals are to help medical personnel worldwide improve lives and to create value for investors, employees and all who use and benefit from its proprietary technology. Please visit www.diamics.com |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion